Literature DB >> 20719860

Subunit interactions influence TSHR multimerization.

Rauf Latif1, Krzysztof Michalek, Terry F Davies.   

Abstract

The TSH receptor (TSHR) is the key molecule influencing thyroid growth and development and is an antigenic target in autoimmune thyroid disease. The TSHR exists in monomeric and multimeric forms, and it has been shown previously that multimeric complexes of the TSHR preferentially localize in lipid rafts. However, unlike other glycoprotein hormone receptors, the TSHR exists in several forms on the cell membrane due to intramolecular cleavage of its ectodomain, which causes the production of α- and β-subunits of various lengths. After cleavage and reduction of disulfide bonds, α-subunits consisting of the receptor ectodomain may be lost from the cell surface by receptor shedding, leading to accumulation of excess β-subunits within the membrane. Because cell surface expression of these various forms of the TSHR is critical to receptor signaling and autoimmune responses, we set out to model the influence of β-subunits on full-length TSHRs. To study this interaction, we generated three truncated ectodomain β-subunits linked to green fluorescent protein (named β-316, -366, and -409) as examples of native cleaved forms of the TSHR. These constructs were transfected into human embryonic kidney 293 cells in the presence and absence of the full-length receptor. Whereas the β-316 and β-366 forms showed cell surface expression, the expression of β-409 was primarily intracellular. Cotransfection of the β-subunits with a full-length hemagglutinin-tagged wild-type (WT) receptor (HT-WT-TSHR) in both transient and stable systems caused a significant decrease in surface expression of the full-length WT receptors. This decrease was not seen with control plasmid consisting of a plasma membrane-targeted protein tagged to red fluorescent protein. To ascertain if this response was due to homointeraction of the truncated β-constructs with the WT-TSHRs, we immunoprecipitated membranes prepared from the cotransfected cells using antihemagglutinin and then probed with anti-green fluorescent protein. These studies confirmed dimerization of the β-subunits with the WT full-length receptor, and this interaction was further observed in vivo by fluorescence resonance energy transfer. We then studied the functional consequences of this interaction on TSHR signaling by examining Gαs-mediated signals. The well-expressed truncated constructs, when coexpressed with full-length TSHR, did not alter constitutive cAMP levels, but there was a significant decrease in TSH-induced cAMP generation. Furthermore, we observed that truncated β-316 and β-366 had faster internalization rate, which may lead to a significant decrease in the expression of the full-length receptor on the cell surface, thus contributing to the decreased signaling response. However, the decrease in surface receptors may also be due to inhibition of newly formed receptors reaching the surface as result of receptor-receptor interaction. It is well known that under normal physiological conditions both cleaved and uncleaved TSHR forms coexist on the cell surface of normal thyrocytes. Our studies allow us to conclude, therefore, that multimerization of cleaved/ truncated forms of the β-subunits with the full-length TSHR has a profound influence on TSHR internalization and signaling. Hence, the degree of intramolecular cleavage must also modulate TSHR signaling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20719860      PMCID: PMC2954635          DOI: 10.1210/me.2010-0001

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  21 in total

1.  Two-subunit structure of the human thyrotropin receptor.

Authors:  H Loosfelt; C Pichon; A Jolivet; M Misrahi; B Caillou; M Jamous; B Vannier; E Milgrom
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

2.  Shedding of human thyrotropin receptor ectodomain. Involvement of a matrix metalloprotease.

Authors:  J Couet; S Sar; A Jolivet; M T Hai; E Milgrom; M Misrahi
Journal:  J Biol Chem       Date:  1996-02-23       Impact factor: 5.157

3.  Oligomerization of the human thyrotropin receptor: fluorescent protein-tagged hTSHR reveals post-translational complexes.

Authors:  R Latif; P Graves; T F Davies
Journal:  J Biol Chem       Date:  2001-09-04       Impact factor: 5.157

4.  The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design.

Authors:  M Zhang; K P Tong; V Fremont; J Chen; P Narayan; D Puett; B D Weintraub; M W Szkudlinski
Journal:  Endocrinology       Date:  2000-09       Impact factor: 4.736

5.  Characterization of the thyrotropin binding pocket.

Authors:  Jennifer Jeffreys; Hilde Depraetere; Jane Sanders; Yasuo Oda; Michele Evans; Angela Kiddie; Tonya Richards; Jadwiga Furmaniak; Bernard Rees Smith
Journal:  Thyroid       Date:  2002-12       Impact factor: 6.568

6.  Ligand-dependent inhibition of oligomerization at the human thyrotropin receptor.

Authors:  Rauf Latif; Peter Graves; Terry F Davies
Journal:  J Biol Chem       Date:  2002-09-09       Impact factor: 5.157

7.  Role of cleavage and shedding in human thyrotropin receptor function and trafficking.

Authors:  Mylène Quellari; Agnès Desroches; Isabelle Beau; Emmanuelle Beaudeux; Micheline Misrahi
Journal:  Eur J Biochem       Date:  2003-09

8.  The thyrotropin receptor hinge region is not simply a scaffold for the leucine-rich domain but contributes to ligand binding and signal transduction.

Authors:  Yumiko Mizutori; Chun-Rong Chen; Sandra M McLachlan; Basil Rapoport
Journal:  Mol Endocrinol       Date:  2008-01-24

9.  Functional assessment of the thyrotropin receptor-beta subunit.

Authors:  I Ciullo; R Latif; P Graves; T F Davies
Journal:  Endocrinology       Date:  2003-07       Impact factor: 4.736

10.  Constitutive activation of the thyrotropin receptor by deletion of a portion of the extracellular domain.

Authors:  M L Zhang; H Sugawa; S Kosugi; T Mori
Journal:  Biochem Biophys Res Commun       Date:  1995-06-06       Impact factor: 3.575

View more
  8 in total

1.  Allosteric modulators hit the TSH receptor.

Authors:  Terry F Davies; M Rejwan Ali; Rauf Latif
Journal:  Endocrinology       Date:  2014-01       Impact factor: 4.736

2.  Transmembrane domains of attraction on the TSH receptor.

Authors:  Rauf Latif; M Rejwan Ali; Mihaly Mezei; Terry F Davies
Journal:  Endocrinology       Date:  2014-11-19       Impact factor: 4.736

Review 3.  Immunopathogenesis of Graves' ophthalmopathy: the role of the TSH receptor.

Authors:  Seethalakshmi Iyer; Rebecca Bahn
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-06       Impact factor: 4.690

Review 4.  Targeting the thyroid-stimulating hormone receptor with small molecule ligands and antibodies.

Authors:  Terry F Davies; Rauf Latif
Journal:  Expert Opin Ther Targets       Date:  2015-03-13       Impact factor: 6.902

5.  Thyroid and bone: macrophage-derived TSH-β splice variant increases murine osteoblastogenesis.

Authors:  R Baliram; A Chow; A K Huber; L Collier; M R Ali; S A Morshed; R Latif; A Teixeira; M Merad; L Liu; L Sun; H C Blair; M Zaidi; T F Davies
Journal:  Endocrinology       Date:  2013-10-18       Impact factor: 4.736

Review 6.  Novel insights on thyroid-stimulating hormone receptor signal transduction.

Authors:  Gunnar Kleinau; Susanne Neumann; Annette Grüters; Heiko Krude; Heike Biebermann
Journal:  Endocr Rev       Date:  2013-05-03       Impact factor: 19.871

Review 7.  Structural-Functional Features of the Thyrotropin Receptor: A Class A G-Protein-Coupled Receptor at Work.

Authors:  Gunnar Kleinau; Catherine L Worth; Annika Kreuchwig; Heike Biebermann; Patrick Marcinkowski; Patrick Scheerer; Gerd Krause
Journal:  Front Endocrinol (Lausanne)       Date:  2017-04-24       Impact factor: 5.555

8.  Antibody protection reveals extended epitopes on the human TSH receptor.

Authors:  Rauf Latif; Avelino Teixeira; Krzysztof Michalek; M Rejwan Ali; Max Schlesinger; Ramkumarie Baliram; Syed A Morshed; Terry F Davies
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.